Skip to main content

Table 1 The mean CMT change in both the groups from week 0 to week 52

From: Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema

Week

Mean CMT 6.0 mg

Std dev CMT 6.0 mg

Mean CMT 3.6 mg

Std dev CMT 3.6 mg

0 week

386.04878

64.5561582

371.463415

47.1747271

4 week

315.512195

56.1961395

310.146341

54.4828234

8 week

283.341463

50.3873048

279.243902

51.6264373

12 week

257.439024

38.0519702

255.780488

37.0759438

16 week

250.365854

42.0504198

254.707317

44.7483206

20 week

260.121951

55.5036914

257.585366

54.3290786

24 week

257.268293

56.4065707

261.268293

57.368556

28 week

278.146341

53.0450568

273.97561

51.1060113

32 week

246.073171

35.1001355

254.682927

46.3699466

36 week

245.878049

36.2044163

257.317073

50.0796561

40 week

269.170732

51.514999

279.170732

62.3758376

44 week

260.560976

42.9651305

272.195122

59.9167003

48 week

250.170732

39.5081653

260.780488

53.2937671

52 week

252.804878

42.8066698

260.853659

48.8306057

  1. “p” value at 0 weeks was 0.82924 and at 52 weeks was 0.84529